Magnesium Citrate

Description

Harris Teeter Magnesium Citrate is a dietary supplement that provides magnesium in the form of citrate. Magnesium citrate is known for its high bioavailability and is commonly used to support various physiological functions, including muscle and nerve function, as well as bone health. The product is typically available in a liquid dosage form, which facilitates ease of administration and absorption. The appearance of Harris Teeter Magnesium Citrate is a clear, colorless to slightly yellow liquid, indicating its purity and quality.

Uses and Indications

This drug is indicated for the relief of occasional constipation (irregularity). It generally produces a bowel movement within 1/2 to 6 hours of administration.

Limitations of Use: There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be shaken well before use. It is recommended that patients drink a full glass (8 ounces) of liquid with each dose to ensure proper administration.

For adults and children aged 12 years and older, the dosage ranges from 6.5 to 10 fluid ounces, with a maximum limit of 10 fluid ounces within a 24-hour period.

For children aged 6 to under 12 years, the appropriate dosage is between 3 to 7 fluid ounces, not exceeding 7 fluid ounces in a 24-hour period.

For children aged 2 to under 6 years, the dosage should be between 2 to 3 fluid ounces, with a maximum of 3 fluid ounces in a 24-hour period.

For children under 2 years of age, it is advised to consult a physician for appropriate dosing recommendations.

The medication may be administered as a single daily dose or divided into multiple doses as deemed necessary.

Contraindications

Use is contraindicated in patients with rectal bleeding or failure to have a bowel movement after use, as these may indicate a serious underlying condition.

Warnings and Precautions

Patients with a history of kidney disease should exercise caution when using this medication, as it may exacerbate their condition. Additionally, individuals on a magnesium-restricted diet must be aware of the potential for increased magnesium levels, which could lead to serious complications.

Abdominal pain, nausea, or vomiting may occur during treatment. If these symptoms manifest, it is advisable to consult a healthcare professional. Furthermore, any sudden change in bowel habits that persists for more than two weeks warrants immediate medical evaluation, as it may indicate an underlying issue. Patients who have been using a laxative for longer than one week should also seek medical advice, as prolonged use can lead to dependency or other gastrointestinal complications.

In the event of an overdose, it is critical to seek emergency medical assistance or contact a Poison Control Center without delay.

Patients should discontinue use and contact their healthcare provider if they experience rectal bleeding or fail to have a bowel movement after administration. These symptoms may signify a serious medical condition that requires prompt attention.

Side Effects

Patients using this medication should be aware of several important warnings and potential adverse reactions. Serious adverse reactions may include symptoms related to kidney disease, which necessitate immediate medical attention. Additionally, patients on a magnesium-restricted diet should exercise caution, as this medication may not be suitable for them.

Common adverse reactions reported include abdominal pain, nausea, and vomiting. Patients should also be vigilant for any sudden changes in bowel habits that persist for more than two weeks, as this may indicate a need for further evaluation. Furthermore, if patients have been using a laxative for longer than one week, they should consult a healthcare professional.

Patients are advised to stop use and seek medical advice if they experience rectal bleeding or failure to have a bowel movement after use, as these symptoms could signify a serious underlying condition.

Drug Interactions

Patients are advised to consult a healthcare professional, such as a doctor or pharmacist, prior to using this product if they are currently taking any other medications.

It is recommended that this product be administered at least 2 hours before or after the use of other drugs. This precaution is particularly important as laxatives may influence the efficacy of concurrent medications. Monitoring for potential interactions is advised to ensure optimal therapeutic outcomes.

Packaging & NDC

Below are the non-prescription pack sizes of Magnesium Citrate (harris teeter magnesium citrate oral solution - lemon). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 to under 12 years may receive a maximum dosage of 3 to 7 fluid ounces within a 24-hour period, with a strict limit of 7 fluid ounces. For children aged 2 to under 6 years, the recommended dosage is 2 to 3 fluid ounces in a 24-hour period, not exceeding 3 fluid ounces. For infants and children under 2 years of age, it is advised to consult a healthcare professional before administration.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients should consult a healthcare professional before using this medication. The potential risks and benefits must be carefully considered, as the effects on fetal outcomes are not fully established. It is essential for women of childbearing potential to discuss their individual circumstances with their healthcare provider to ensure appropriate management during pregnancy.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating mothers.

Renal Impairment

Patients with renal impairment may require careful consideration regarding dosing adjustments and monitoring. In individuals with reduced kidney function, particularly those with kidney disease, it is essential to assess renal clearance to ensure appropriate medication management. Additionally, patients on a magnesium-restricted diet should be monitored closely, as renal impairment can affect magnesium levels and overall electrolyte balance. Regular evaluation of renal function is recommended to guide therapy and prevent potential complications associated with altered drug metabolism and excretion.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is important to note that there is no specific information available regarding the effects or management of such an occurrence as outlined in the provided sections of the Structured Product Labeling (SPL).

Healthcare professionals are advised to monitor the patient closely for any potential symptoms that may arise, despite the absence of documented overdosage data. Standard supportive care should be initiated as necessary, and symptomatic treatment should be provided based on the clinical presentation of the patient.

In the absence of specific antidotes or treatment protocols, it is recommended that healthcare providers consult local poison control centers or relevant medical authorities for guidance on managing suspected overdosage cases. Continuous assessment and supportive measures are essential in ensuring patient safety and well-being.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose. It is important for patients to be aware of the signs that warrant discontinuation of the product; they should stop use and consult a doctor if they experience rectal bleeding or fail to have a bowel movement after use, as these symptoms may indicate a serious condition.

Patients should also be encouraged to consult with their healthcare provider or pharmacist prior to using this product if they are currently taking any other medications. It is essential to inform patients that this product should be taken at least 2 hours before or after the administration of other drugs, as laxatives may influence the effectiveness of concurrent medications.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at temperatures ranging from 46° to 86°F (8° to 30°C) to maintain its efficacy and safety. Proper container requirements must be adhered to, ensuring that the product is kept in an appropriate environment. Special handling needs should be observed to prevent any compromise to the product's integrity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Magnesium Citrate, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)